Stay updated on COR388 for AD: Phase 2/3 Clinical Trial
Sign up to get notified when there's something new on the COR388 for AD: Phase 2/3 Clinical Trial page.

Latest updates to the COR388 for AD: Phase 2/3 Clinical Trial page
- Check2 days agoNo Change Detected
- Check9 days agoChange DetectedThe web page has been updated from version 2.15.0 to version 2.15.2, indicating a revision in the content.SummaryDifference0.1%
- Check16 days agoNo Change Detected
- Check23 days agoChange DetectedThe page has undergone significant content changes regarding the study of COR388 for Alzheimer's Disease, including the removal of detailed study descriptions and key inclusion/exclusion criteria, while retaining the mention of Alzheimer's Disease and the study identifier COR388-010.SummaryDifference19%
- Check30 days agoChange DetectedThe web page has been updated from version 2.14.3 to version 2.14.4.SummaryDifference0.1%
- Check38 days agoChange DetectedThe web page has been updated from version 2.14.2 to version 2.14.3.SummaryDifference0.1%
- Check74 days agoChange DetectedThe page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.SummaryDifference1%
- Check88 days agoChange DetectedThe page now includes a notice about heavy traffic affecting the performance and availability of some NLM-NCBI services and products, along with contact information for assistance.SummaryDifference1%
Stay in the know with updates to COR388 for AD: Phase 2/3 Clinical Trial
Enter your email address, and we'll notify you when there's something new on the COR388 for AD: Phase 2/3 Clinical Trial page.